The Rho guanine nucleotide exchange factor DrhoGEF2 is a genetic modifier of the PI3K pathway in Drosophila

Ying Ju Chang, Lily Zhou, Richard Binari, Armen Manoukian, Tak Mak, Helen McNeill, Vuk Stambolic

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

The insulin/IGF-1 signaling pathway mediates various physiological processes associated with human health. Components of this pathway are highly conserved throughout eukaryotic evolution. In Drosophila, the PTEN ortholog and its mammalian counterpart downregulate insulin/IGF signaling by antagonizing the PI3-kinase function. From a dominant loss-of-function genetic screen, we discovered that mutations of a Dbl-family member, the guanine nucleotide exchange factor DRhoGEF2 (DRhoGEF22(l)04291), suppressed the PTEN-overexpression eye phenotype. dAkt/dPKB phosphorylation, a measure of PI3K signaling pathway activation, increased in the eye discs from the heterozygous DRhoGEF2 wandering third instar larvae. Overexpression of DRhoGEF2, and it’s functional mammalian ortholog PDZ-RhoGEF (ArhGEF11), at various stages of eye development, resulted in both dPKB/Aktdependent and -independent phenotypes, reflecting the complexity in the crosstalk between PI3K and Rho signaling in Drosophila.

Original languageEnglish
Article numbere0152259
JournalPloS one
Volume11
Issue number3
DOIs
StatePublished - Mar 2016
Externally publishedYes

Fingerprint Dive into the research topics of 'The Rho guanine nucleotide exchange factor DrhoGEF2 is a genetic modifier of the PI3K pathway in Drosophila'. Together they form a unique fingerprint.

  • Cite this